CLDI Calidi Biotherapeutics, Inc.

NYSE www.calidibio.com


$ 1.60 $ 0.11 (7.38 %)    

Thursday, 06-Nov-2025 12:04:13 EST
QQQ $ 612.06 $ -9.60 (-1.54 %)
DIA $ 468.56 $ -3.47 (-0.74 %)
SPY $ 670.21 $ -6.25 (-0.93 %)
TLT $ 89.79 $ 0.23 (0.26 %)
GLD $ 366.52 $ -0.68 (-0.19 %)
$ 1.5
$ 1.49
$ 1.52 x 35
$ 1.60 x 2,676
$ 1.49 - $ 1.60
$ 1.41 - $ 46.68
71,765
na
5.14M
$ 0.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-15-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-21-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

On October 27, 2025, Calidi Biotherapeutics, Inc. (the "Company") entered into that certain Stock Repurchase Agreement ...

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a clinical-stage biotechnology company pi...

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a clinical-stage biotechnology company pi...

Core News & Articles

Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION